Sunmax Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Sunmax Biotechnology has a total shareholder equity of NT$1.2B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$2.4B and NT$1.2B respectively. Sunmax Biotechnology's EBIT is NT$938.5M making its interest coverage ratio -89.5. It has cash and short-term investments of NT$1.2B.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -89.5x |
| Cash | NT$1.16b |
| Equity | NT$1.19b |
| Total liabilities | NT$1.20b |
| Total assets | NT$2.39b |
Recent financial health updates
No updates
Recent updates
Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%
Feb 28
Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?
Feb 02Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?
Dec 20Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?
Nov 24
Financial Position Analysis
Short Term Liabilities: 4728's short term assets (NT$1.4B) exceed its short term liabilities (NT$962.7M).
Long Term Liabilities: 4728's short term assets (NT$1.4B) exceed its long term liabilities (NT$240.3M).
Debt to Equity History and Analysis
Debt Level: 4728 is debt free.
Reducing Debt: 4728 had no debt 5 years ago.
Debt Coverage: 4728 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4728 has no debt, therefore coverage of interest payments is not a concern.